DisGeNET

DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.

Source Last Updated
DisGeNET July 29, 2024
Displaying entries 12851 - 12875 of 62743 in total
Disease ID Disease Name Gene Symbol Gene ID Gene Name ▲ UniProt ID
C0038356 Stomach Neoplasms MGAT5 4249 alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase Q09328
C0020459 Hyperinsulinism MGAT5 4249 alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase Q09328
C1621958 Glioblastoma Multiforme MGAT5 4249 alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase Q09328
C0699791 Stomach Carcinoma MGAT5 4249 alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase Q09328
C0017636 Glioblastoma MGAT5 4249 alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase Q09328
C0700095 Central neuroblastoma MGAT5B 146664 alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B Q3V5L5
C1136382 Sclerocystic Ovaries MGAT5B 146664 alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B Q3V5L5
C0027819 Neuroblastoma MGAT5B 146664 alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B Q3V5L5
C0006826 Malignant Neoplasms MGAT5B 146664 alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B Q3V5L5
C0153633 Malignant neoplasm of brain MGAT5B 146664 alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B Q3V5L5
C2239176 Liver carcinoma MGAT5B 146664 alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B Q3V5L5
C0279702 Conventional (Clear Cell) Renal Cell Carcinoma MGAT5B 146664 alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B Q3V5L5
C0016788 Fucosidase Deficiency Disease FUCA1 2517 alpha-L-fucosidase 1 P04066
C1527336 Sjogren's Syndrome FUCA1 2517 alpha-L-fucosidase 1 P04066
C0036572 Seizures FUCA1 2517 alpha-L-fucosidase 1 P04066
C0086795 Pfaundler-Hurler Syndrome FUCA1 2517 alpha-L-fucosidase 1 P04066
C0006142 Malignant neoplasm of breast FUCA1 2517 alpha-L-fucosidase 1 P04066
C0040136 Thyroid Neoplasm FUCA1 2517 alpha-L-fucosidase 1 P04066
C0006826 Malignant Neoplasms FUCA1 2517 alpha-L-fucosidase 1 P04066
C0020676 Hypothyroidism FUCA1 2517 alpha-L-fucosidase 1 P04066
C1306459 Primary malignant neoplasm FUCA1 2517 alpha-L-fucosidase 1 P04066
C1384666 hearing impairment FUCA1 2517 alpha-L-fucosidase 1 P04066
C0162819 Skin Diseases, Vascular FUCA1 2517 alpha-L-fucosidase 1 P04066
C0235946 Cerebral atrophy FUCA1 2517 alpha-L-fucosidase 1 P04066
C0027533 Neck Neoplasms FUCA1 2517 alpha-L-fucosidase 1 P04066

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024